Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 125,341 | 320,268 | 251,671 | 227,868 | 153,616 |
| Cost of Goods | 60,065 | 77,725 | 62,134 | 43,466 | 35,858 |
| Gross Profit | 65,276 | 242,543 | 189,537 | 184,402 | 117,758 |
| Operating Expenses | 52,547 | 41,335 | 38,811 | 25,595 | 19,718 |
| Operating Income | 12,794 | 201,933 | 150,860 | 159,273 | 98,898 |
| Other Income | 958 | 45 | -35 | 496 | 4,338 |
| Pre-tax Income | 13,752 | 201,978 | 150,825 | 159,769 | 103,236 |
| Income Tax | 2,653 | 48,421 | 47,148 | 37,545 | 23,589 |
| Net Income Continuous | 11,099 | 153,557 | 103,677 | 122,224 | 79,647 |
| Minority Interests | -438 | -422 | -662 | -298 | -165 |
| Net Income | $11,537 | $153,979 | $104,339 | $122,522 | $79,812 |
| EPS Basic Total Ops | 0.38 | 5.09 | 3.42 | 4.13 | 2.74 |
| EPS Basic Continuous Ops | 0.37 | 5.08 | 3.40 | 4.12 | 2.73 |
| EPS Diluted Total Ops | 0.37 | 4.93 | 3.34 | 3.93 | 2.59 |
| EPS Diluted Continuous Ops | 0.36 | 4.92 | 3.32 | 3.92 | 2.58 |
| EBITDA(a) | $22,452 | $208,538 | $156,457 | $164,765 | $103,184 |